Prognostic factors for early mortality in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 21, Issue 3, 2015, Pages 226-230

  Oosterveld, Linda P ^a,c   Allen, John C ^b   Reinoso, Giselle ^a,b   Seah, Soo Hoon ^a   Tay, Kay Yaw ^a   Au, Wing Lok ^a   Tan, Louis C S ^a  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Mortality; Parkinson's disease; Prognostic factors; Survival

Indexed keywords

AMANTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; SELEGILINE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; BRADYKINESIA; CAUSE OF DEATH; COGNITIVE DEFECT; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SENESCENCE; SEX DIFFERENCE; SURVIVAL TIME; UNIFIED PARKINSON DISEASE RATING SCALE; AGE; AGED; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MIDDLE AGED; REGRESSION ANALYSIS;

AGE FACTORS; AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARKINSON DISEASE; PROGNOSIS; REGRESSION ANALYSIS; SEX FACTORS;

EID: 84923251428     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.12.011     Document Type: Article

References (30)

1. Ishihara L.S., Cheesbrough A., Brayne C., Schrag A. Estimated life expectancy of Parkinson's patients compared with the UK population. JNeurol Neurosurg Psychiatr 2007, 78:1304-1309. 10.1136/jnnp.2006.100107.
2. Macleod A.D., Taylor K.S.M., Counsell C.E. Mortality in Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2014 May 13, [Epub ahead of print]. 10.1002/mds.25898.
3. Vu T.C., Nutt J.G., Holford N.H. Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease. Br J Clin Pharmacol 2012, 74:284-295. 10.1111/j.1365-2125.2012.04208.x.
4. Marras C., McDermott M.P., Rochon P.A., Tanner C.M., Naglie G., Rudolph A., et al. Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. Neurology 2005 Jan 11, 64:87-93.
5. Auyeung M., Tsoi T.H., Mok V., Cheung C.M., Lee C.N., Li R., et al. Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients. JNeurol Neurosurg Psychiatr 2012, 83:607-611. 10.1136/jnnp-2011-301590.
6. Forsaa E.B., Larsen J.P., Wentzel-Larsen T., Alves G. What predicts mortality in Parkinson disease?: a prospective population-based long-term study. Neurology 2010, 75:1270-1276. 10.1212/WNL.0b013e3181f61311.
7. Willis A.W., Schootman M., Kung N., Evanoff B.A., Perlmutter J.S., Racette B.A. Predictors of survival in patients with Parkinson disease. Arch Neurol 2012, 69:601-607. 10.1001/archneurol.2011.2370.
8. Chillag-Talmor O., Giladi N., Linn S., Gurevich T., El-Ad B., Silverman B., et al. Estimation of Parkinson's disease survival in Israeli men and women, usinghealth maintenance organization pharmacy data in a unique approach. JNeurol 2013, 260:62-70. 10.1007/s00415-012-6584-5.
9. Ngoga D., Mitchell R., Kausar J., Hodson J., Harries A., Pall H. Deep brain stimulation improves survival in severe Parkinson's disease. JNeurol Neurosurg Psychiatr 2014, 85:17-22. 10.1136/jnnp-2012-304715.
10. Hughes T.A., Ross H.F., Mindham R.H., Spokes E.G. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand 2004 Aug, 110(2):118-123.
11. Lo R.Y., Tanner C.M., Albers K.B., Leimpeter A.D., Fross R.D., Bernstein A.L., et al. Clinical features in early Parkinson disease and survival. Arch Neurol 2009, 66:1353-1358. 10.1001/archneurol.2009.221.
12. Duarte J., García Olmos L.M., Mendoza A., Clavería L.E. The natural history of Parkinson's disease in the province of Segovia: mortality in a longitudinal study (20-year follow-up). Acta Neurol Scand 2013, 127:295-300. 10.1111/ane.12003.
13. Peretz C., Chillag-Talmor O., Linn S., Gurevich T., El-Ad B., Silverman B., et al. Parkinson's disease patients first treated at age 75 years or older: a comparative study. Parkinsonism Relat Disord 2014, 20:69-74. 10.1016/j.parkreldis.2013.09.020.
14. Xu J., Gong D.D., Man C.F., Fan Y. Parkinson's disease and risk of mortality: meta-analysis and systematic review. Acta Neurol Scand 2014, 129:71-79. 10.1111/ane.12201.
15. Diem-Zangerl A., Seppi K., Wenning G.K., Trinka E., Ransmayr G., Oberaigner W., et al. Mortality in Parkinson's disease: a 20-year follow-up study. Mov Disord 2009, 24:819-825.
16. Levy G., Tang M.X., Louis E.D., CÔté L.J., Alfaro B., Mejia H., et al. The association of incident dementia with mortality in PD. Neurology 2002, 59:1708-1713.
17. De Lau L.M., Schipper C.M., Hofman A., Koudstaal P.J., Breteler M.M. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol 2005, 62:1265-1269.
18. De Lau L.M., Verbaan D., Marinus J., van Hilten J.J. Survival in Parkinson's disease. Relation with motor and non-motor features. Parkinsonism Relat Disord 2014, 20:613-616. 10.1016/j.parkreldis.2014.02.030.
19. Hobson P., Meara J., Ishihara-Paul L. The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population. JNeurol Neurosurg Psychiatr 2010, 81:1093-1098. 10.1136/jnnp.2009.198689.
20. Posada I.J., Benito-León J., Louis E.D., Trincado R., Villarejo A., Medrano M.J., et al. Mortality from Parkinson's disease: a population-based prospective study (NEDICES). Mov Disord 2011, 26:2522-2529. 10.1002/mds.23921.
21. Park J.E., Lee J.Y., Suh G.H., Kim B.S., Cho M.J. Mortality rates and predictors in community-dwelling elderly individuals with cognitive impairment: an eight-year follow-up after initial assessment. Int Psychogeriatr 2014, 26:1295-1304. 10.1017/S1041610214000556.
22. Todd S., Barr S., Roberts M., Passmore A.P. Survival in dementia and predictors of mortality: a review. Int J Geriatr Psychiatry 2013, 28:1109-1124. 10.1002/gps.3946.
23. Guehne U., Riedel-Heller S., Angermeyer M.C. Mortality in dementia. Neuroepidemiology 2005, 25:153-162.
24. Hu F., Jiang C., Shen J., Tang P., Wang Y. Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis. Injury 2012, 43:676-685. 10.1016/j.injury.2011.05.017.
25. Chien C.C., Wang J.J., Sun Y.M., Sun D.P., Sheu M.J., Weng S.F., et al. Long-term survival and predictors for mortality among dialysis patients in an endemic area for chronic liver disease: a national cohort study in Taiwan. BMC Nephrol 2012, 13:43. 10.1186/1471-2369-13-43.
26. Narasimhalu K., Ang S., De Silva D.A., Wong M.C., Chang H.M., Chia K.S., et al. The prognostic effects of poststroke cognitive impairment no dementia and domain-specific cognitive impairments in nondisabled ischemic stroke patients. Stroke 2011, 42:883-888. 10.1161/STROKEAHA.110.594671.
27. Hely M.A., Morris J.G., Traficante R., Reid W.G., O'Sullivan D.J., Williamson P.M. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. JNeurol Neurosurg Psychiatr 1999, 67:300-307.
28. Reinoso G., Allen J.C., Au W.L., Seah S.H., Tay K.Y., Tan L.C.S. Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study. Eur J Neurol 2014 Jun 2, [Epub ahead of print]. 10.1111/ene.12476.
29. Selikhova M., Williams D.R., Kempster P.A., Holton J.L., Revesz T., Lees A.J. Aclinico-pathological study of subtypes in Parkinson's disease. Brain 2009, 132:2947-2957. 10.1093/brain/awp234.
30. Liou H.H., Wu C.Y., Chiu Y.H., Yen A.M., Chen R.C., Chen T.F. Mortality of Parkinson's disease by Hoehn-Yahr stage from community-based and clinic series [Keelung Community-based Integrated Screening (KCIS) no. 17)]. JEval Clin Pract 2009, 15:587-591. 10.1111/j.1365-2753.2008.01041.x.